In contrast, there were no significant differences in the diagnostic value of the γ-GT/ALT ratio among these patients, suggesting that the γ-GT/ALT ratio may be more useful in the diagnosis of patients with HCC who were negative for HBV DNA. This evidence concerns the gene GPT and hepatocellular carcinoma.